Calumet (CLMT) Valuation Revisited After Strong Multi Month Share Price Rally

Calumet, Inc. +1.36%

Calumet, Inc.

CLMT

35.06

+1.36%

Calumet (CLMT) has drawn investor attention after recent trading, with the shares closing at $30.22 and posting strong gains over the past month and past 3 months. That move raises fresh questions about valuation and risk.

The recent 36.56% 1 month share price return and 56.58% 3 month share price return, alongside a 1 year total shareholder return of 101.74%, indicate that momentum has been building rather than fading for Calumet.

If this move in Calumet has you considering other opportunities in energy and infrastructure, it could be a good moment to review 23 power grid technology and infrastructure stocks as a next step.

With Calumet now at $30.22, a value score of 1, recent annual revenue of $4,048.0 and a net income loss of $37.2, the key question is simple: is there still a buying opportunity here or has the market already priced in future growth?

Most Popular Narrative: 28.9% Overvalued

Calumet's most followed narrative pegs fair value at $23.45, well below the current $30.22 share price. This frames the recent rally in a different light.

The MaxSAF 150 project is on track to start up in the first half of 2026, enabling Calumet to produce 120-150 million annual gallons of sustainable aviation fuel (SAF) at relatively low capital costs, capturing premiums of $1-$2/gallon over renewable diesel and tapping into surging mandated and voluntary SAF demand globally; this is likely to drive material step-up in revenues and EBITDA margin expansion once operational.

Want to see what kind of revenue mix, margin profile, and future earnings multiple sit behind that fair value? The narrative leans heavily on a specific growth runway and a richer valuation benchmark that is very different from typical oil and gas assumptions.

Result: Fair Value of $23.45 (OVERVALUED)

However, this story still hinges on supportive regulation for renewables and on Calumet managing its substantial debt load without limiting future investment options.

Next Steps

With both risks and rewards on the table, does Calumet’s recent run fit your comfort zone, or not quite yet? Take a moment to review the details, weigh the concerns against the potential upside, and let 2 key rewards and 2 important warning signs help you shape your own conclusion.

Looking for more investment ideas?

If Calumet feels interesting but not quite enough on its own, you can broaden your watchlist with focused stock ideas that match how you like to invest.

  • Target value first and see whether our list of 54 high quality undervalued stocks lines up with the kind of pricing discipline you want to keep.
  • Prioritise resilience and check out companies in the 80 resilient stocks with low risk scores that may better fit a steadier approach to building wealth.
  • Hunt for potential future standouts by scanning the screener containing 24 high quality undiscovered gems, so you are not only reacting to the stories everyone already knows.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.